Breakthrough in Esophageal Cancer treatment thanks to 3D printed stents

Researchers from the University of South Australia have developed 3D printed esophageal stents that could revolutionise the delivery of chemotherapy drugs for patients with esophageal cancer. 3D printing has become of increasing importance in the medical field as it allows for more accurate, effective and personalized treatment of patients. In this specific case, by using fused deposition modeling (FDM), the researchers were able to create a stent that could diffuse the chemotherapy drug 5-fluorouracil (5-FU), over a sustained, longer period of time. As esophageal cancer is the seventh most common cancer in the world, while being the sixth highest cause of all cancer deaths worldwide, this stent could prove to be a breakthrough in treatment of the disease.

The 3D printed esophageal stents

Esophageal cancer is one of the most common cancers worldwide. It is also one of the most deadly, with a 5 year survival rate ranging from 5 to 30% depending on the stage and severity of the case. These 3D printed esophageal stents aim to help patients in two major ways. First, they will help to relieve symptoms of the disease, targeting dysphagia, which prevents patients from swallowing certain foods or liquids. The stents can keep a blocked passageway open in order to ease eating and drinking for patients. These stents however will serve another purpose as well, they are designed to deliver 110 days of sustained anti-cancer medication directly to the cancer site. This is important as often with these kinds of stents, the growing tumor can invade the area and move them, making them ineffective at best. They are the first esophageal stents to contain active pharmaceutical ingredients within their matrix, a design that is possible thanks to 3D printing.

Speaking on the use of the stents, PhD Scholar Fouladian explains, “Blockages are commonly eased by an oesophageal stent – a small tube that is placed in the food pipe to keep it open – but these too can become obstructed by invading cancer cells.Our new drug-loaded oesophageal stents can help prevent further blockages by administering anti-cancer drugs directly to the tumour, limiting further growth while relieving the pressure of dysphagia.”